Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT04988009
- Status
- Recruiting
Conditions
- Central Nervous System Neoplasm
- Leptomeningeal Neoplasm
- Metastatic Malignant Neoplasm in the Brain
- Primary Brain Neoplasm
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Electronic Health Record Review — OTHERReview of medical chart
- Survey Administration — OTHERComplete survey
Study Details
This study evaluates patient perceptions around quality of care through telemedicine in neuro-oncology. Studying questionnaires related to perceptions quality of care through telemedicine in patients with brain cancer may help doctors to improve the delivery of care through this modality.
Key Dates
- Start date
- Aug 20, 2020
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 200 participants (estimated)
Arms
- Arm: Observational (survey, medical chart review)Patients complete a survey related to their perceived quality of care via telephone and have their medical chart reviewed prospectively.
Primary Outcome Measure
Survey response to question 6 of the quality of care survey ("I felt I received good medical care during this encounter") [ Time Frame: through study completion, an average of 1 year ]
Central Contacts
- Barbara J O'Brien, MD713-794-4380
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| M D Anderson Cancer Center | Houston | Texas | 77030 | Barbara J O'Brien, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By research site
Related Studies
- Project: Every Child for Younger Patients With CancerRecruiting · Children's Oncology Group · Birmingham, Alabama
- Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain TumorsRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal DiseasePHASE1 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas
- S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityPHASE3 · Recruiting · SWOG Cancer Research Network · Anchorage, Alaska